Stock RPHM RENEO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Real-time Estimate Cboe BZX
Other stock markets
 03:10:56 2024-05-01 pm EDT 		5-day change 1st Jan Change
1.74 USD +4.19% Intraday chart for Reneo Pharmaceuticals, Inc. +4.17% +9.38%
Mar. 28 Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 North American Morning Briefing : Tech in Focus on -2- DJ

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Insider Buy: Reneo Pharmaceuticals
MT
Reneo Pharmaceuticals, Inc. Appoints Roshawn Blunt to Its Board of Directors
CI
Dr. Lon Cardon Not Stands for Re-Election as Member of the Board of Reneo Pharmaceuticals, Inc
CI
Reneo Pharmaceuticals Names New COO
MT
Reneo Pharmaceuticals, Inc. Announces Senior Leadership Promotions
CI
Vineet R. Jindal to Resign as Reneo Pharmaceuticals, Inc.'s Chief Financial Officer, Effective March 31, 2022
CI
Reneo Pharmaceuticals Announces Changes to its Board of Directors
CI
Reneo Pharmaceuticals, Inc. Announces Board Changes
CI
Reneo Pharmaceuticals, Inc. Appoints Ashley F. Hall as Chief Development Officer
CI
Reneo Pharmaceuticals, Inc. Announces Retirement of Wendy Johnson as Chief Development Officer, Effective on or Before December 31, 2021
CI
Reneo Pharmaceuticals Appoints Vineet R. Jindal as its Chief Financial Officer
CI
Reneo Pharmaceuticals, Inc. Appoints Eric Dube to Its Board of Directors
CI
Reneo Pharmaceuticals, Inc. Appoints Gregory J. Flesher as President and A Member of the Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RPHM Stock
  4. News Reneo Pharmaceuticals, Inc.
  5. Insiders